Package Leaflet: Information for the User
Venlafaxine Bluefish 75 mg prolonged-release capsules EFG
venlafaxine
Contents of the pack:
Venlafaxine Bluefish belongs to a group of medicines called antidepressants, selective serotonin and noradrenaline reuptake inhibitors (SSNRIs). It is used in the treatment of depression and other conditions such as anxiety disorders. It is not fully understood how antidepressants work, but they may help by increasing the levels of serotonin and noradrenaline in the brain.
Venlafaxine Bluefish is a treatment for adults with depression. Venlafaxine Bluefish is also a treatment for adults with the following anxiety disorders: generalised anxiety disorder, social anxiety disorder (fear of social or performance situations), panic disorder (recurring panic attacks). It is important to treat depression or anxiety disorders properly to improve your condition. If left untreated, your condition will persist and may become worse and more difficult to treat.
Do not take Venlafaxine Bluefish
Warnings and precautions
Consult your doctor, pharmacist or nurse before you start taking Venlafaxine Bluefish
Tell your doctor or pharmacist before you start taking Venlafaxine Bluefish, especially if you suffer from:
These conditions can occur with:
Careful observation of the patient during treatment is advised, particularly when combining other agents with venlafaxine, as this combination may have an undesired effect on serotonin and dopamine levels.
Venlafaxine Bluefish may cause a feeling of restlessness and an urgent need to move, often accompanied by difficulty sitting or standing still, during the first few weeks of treatment. If this happens, you should tell your doctor.
Do not drink alcohol while taking Venlafaxine Bluefish. Taking it with alcohol may cause extreme tiredness and unconsciousness. Taking it with certain medicines or alcohol may worsen the symptoms of depression and other conditions, such as anxiety disorders.
Suicidal thoughts and worsening of depression or anxiety disorder
If you are depressed and/or have an anxiety disorder, you may sometimes have thoughts of harming or killing yourself. These thoughts may be more likely when you first start taking antidepressants, since these medicines all take time to work, usually about 2 weeks, but sometimes longer.
You are more likely to think this way:
If you have thoughts of harming or killing yourself at any time, contact your doctor or go to hospital straight away.
Tell a friend or relative that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.
Dry mouth
Dry mouth has been reported in approximately 10% of patients treated with venlafaxine. This may increase the risk of tooth decay. Therefore, you should be careful with your dental hygiene.
Diabetes
Your blood glucose levels may be altered due to Venlafaxine Bluefish. Therefore, the doses of your diabetes medicines may need to be adjusted.
Some medicines in the same class as Venlafaxine Bluefish (so-called SSRIs/ SNRIs) may cause sexual dysfunction (see section 4.8). In some cases, these symptoms have persisted after stopping treatment.
Children and adolescents
Venlafaxine Bluefish should not normally be used in the treatment of children and adolescents under 18 years. Furthermore, you should know that in patients under 18 years, there is an increased risk of adverse reactions such as suicide attempt, suicidal ideation and hostility (predominantly aggression, oppositional behaviour and anger) when they take this class of medicines. Nevertheless, your doctor may prescribe Venlafaxine Bluefish to patients under 18 years when it is decided that it is the best option for the patient. If the doctor who prescribed Venlafaxine Bluefish to a patient under 18 years decides to do so, please go back to see the doctor. You should tell your doctor if any of the symptoms described above get worse or if you experience any difficulties when patients under 18 years are taking Venlafaxine Bluefish. Furthermore, the long-term safety of Venlafaxine Bluefish in this age group concerning growth, maturation and cognitive and behavioural development has not yet been demonstrated.
Other medicines and Venlafaxine Bluefish
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Your doctor will decide whether you can take Venlafaxine Bluefish with other medicines.
Do not start or stop taking any medicines, including those bought without a prescription, herbal or homeopathic remedies, without first checking with your doctor or pharmacist.
Examples of these medicines include:
The signs and symptoms of serotonin syndrome may include a combination of: agitation, hallucinations, loss of coordination, rapid heart beat, increased body temperature, rapid changes in blood pressure, overactive reflexes, diarrhoea, coma, nausea, vomiting. In its most severe form, serotonin syndrome can resemble Neuroleptic Malignant Syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heart beat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by a blood test).
Tell your doctor immediately or go to the casualty department of the nearest hospital if you think you are experiencing serotonin syndrome.
The following medicines may also interact with Venlafaxine Bluefish and should be used with caution. It is very important that you tell your doctor or pharmacist if you are taking medicines that contain:
Taking Venlafaxine Bluefish with food, drinks and alcohol
Venlafaxine Bluefish should be taken with food (see section 3).
Do not drink alcohol while taking Venlafaxine Bluefish. Taking it with alcohol may cause extreme tiredness and unconsciousness, and worsen the symptoms of depression and other conditions, such as anxiety disorders.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. You should only take Venlafaxine Bluefish after discussing the potential benefits and risks with your doctor.
Tell your doctor or midwife you are taking Venlafaxine Bluefish. During pregnancy, medicines like SSRIs may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), which makes the baby breathe faster and look bluish. These symptoms start during the first 24 hours after birth. If this happens to your baby, contact your doctor or midwife immediately.
If you are taking Venlafaxine Bluefish during pregnancy, other symptoms your baby may have after birth are problems with feeding and breathing. If your baby has these symptoms and you are concerned, contact your doctor.
If you take Venlafaxine Bluefish in the final stages of pregnancy, you may experience an increased risk of heavy vaginal bleeding after giving birth, especially if you have a history of bleeding disorders. Your doctor or midwife should be aware that you are taking Venlafaxine Bluefish so they can advise you.
Venlafaxine passes into breast milk, so you should not take the medicine if you are breast-feeding your baby. There is a risk of an effect on the baby. Therefore, you should discuss this with your doctor and they will decide whether you should stop breast-feeding or stop Venlafaxine Bluefish treatment.
Driving and using machines
Do not drive or use any tools or machines until you know how Venlafaxine Bluefish affects you.
Take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended starting dose for the treatment of depression, generalised anxiety disorder and social anxiety disorder is 75 mg once daily. Your doctor may gradually increase the dose up to a maximum of 375 mg daily for depression. If you are being treated for panic disorder, your doctor will start you on a lower dose (37.5 mg) and then gradually increase it. The maximum dose for generalised anxiety disorder, social anxiety disorder and panic disorder is 225 mg/day.
Take Venlafaxine Bluefish at approximately the same time each day, either in the morning or in the evening. The capsules should be swallowed whole with a little water, without opening, crushing, chewing or dissolving. Chewing, crushing or dissolving the capsule contents may damage the coating and affect the way the medicine is released.
Venlafaxine Bluefish should be taken with food.
Patients with liver or kidney problems:
If you have liver or kidney problems, consult your doctor as your dose of Venlafaxine Bluefish may need to be adjusted.
Do not stop taking Venlafaxine Bluefish without talking to your doctor (see section “If you stop taking Venlafaxine Bluefish”).
If you take more Venlafaxine Bluefish than you should
If you have taken too much Venlafaxine Bluefish, contact your doctor or pharmacist or go to the casualty department of the nearest hospital immediately. Take the medicine pack with you. Symptoms of overdose are listed below.
Taking too much Venlafaxine Bluefish may lead to severe consequences and may be life-threatening, especially when taken with other medicines and/or alcohol (see “Taking Venlafaxine Bluefish with other medicines”).
Symptoms of overdose may include: rapid heart beat, changes in level of consciousness (ranging from drowsiness to coma), blurred vision, fits or seizures, and vomiting.
If you forget to take Venlafaxine Bluefish
If you miss a dose, take it as soon as you remember. However, if it is time for your next dose, skip the missed dose and take the next one as usual. Do not take a double dose to make up for a forgotten dose.
If you stop taking Venlafaxine Bluefish
Do not stop taking your treatment or reduce the dose without the advice of your doctor even if you feel better. If your doctor thinks that you no longer need Venlafaxine Bluefish, your doctor will gradually reduce your dose before stopping treatment completely. It is known that when this medicine is stopped, you may experience side effects. These are usually mild and stop on their own in a few weeks. In some cases, stopping treatment or reducing the dose may cause symptoms such as: dizziness, headache, nausea, vomiting, irritability, agitation, confusion, numbness or tingling, anxiety, fatigue, insomnia, excessive sweating, and vertigo.
Your doctor will advise you on how to stop taking Venlafaxine Bluefish. If you experience any of these or other symptoms that are troublesome, contact your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If any of the following effects occur, do not take more Venlafaxina Bluefish. Tell your doctor immediately, or go to the emergency department of the nearest hospital:
Other adverse effects that you should inform your doctor aboutare:
Do not worry if you notice small granules or white balls in your stools after taking this medicine. Inside the Venlafaxina Bluefish capsules, there are spheroids (small white balls) that contain the active ingredient (venlafaxine). These spheroids are released from the capsule in the stomach. As they circulate through the stomach and intestines, venlafaxine is slowly released. The "shell" of the spheroid does not dissolve and comes out in the stools. Therefore, even if you see spheroids in the stools, the dose of the medicine has been absorbed.
Complete list of adverse effects
Very common (affects more than 1 in 10 patients)
Common (affects between 1 and 10 in 100 patients)
Uncommon (affects between 1 and 10 in 1,000 patients)
Rare (affects between 1 and 10 in 10,000 patients)
Frequency not known (frequency cannot be estimated from available data)
Venlafaxina Bluefish sometimes causes undesirable effects that you may not be aware of, such as hypertension or abnormal heartbeat; slight changes in liver enzyme, sodium, or cholesterol blood levels. Rarely, venlafaxine may reduce the function of platelets in the blood, increasing the risk of bruising or bleeding. Therefore, it is best that your doctor performs occasional blood tests; especially if you are taking venlafaxine for a long time.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use http://www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging after "Cad". The expiration date refers to the last day of that month.
Do not store above 30°C.
Do not use this medicine if you notice that the capsules are sticky.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines that you no longer need at the SIGRE collection point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.
Venlafaxina Bluefish composition
The active ingredient is venlafaxine.
Each capsule contains: Venlafaxine hydrochloride, which corresponds to 75 mg of venlafaxine.
The other ingredients are:
Core
Microcrystalline cellulose, povidone, talc, colloidal anhydrous silica, magnesium stearate.
Coating
Ethyl cellulose, copovidone.
Capsule
Black iron oxide (E-172), red iron oxide (E-172), titanium dioxide (E-171), and gelatin.
Printing inks
Shellac and red iron oxide.
Product appearance and package contents
Hard gelatin capsule of prolonged release.
75 mg:hard gelatin capsules with peach-colored opaque body and cap, size "1", with thick and thin radial red bands on the body, and thick and thin radial red bands on the cap. Each capsule contains 6 white to off-white, round, biconvex film-coated mini-tablets.
PVC/Aclar and aluminum blister packs with: 10, 14, 28, 30, 50, and 100 capsules.
PVC/PVdC and aluminum blister packs with: 10, 14, 28, 30, 50, and 100 capsules.
Only some pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Bluefish Pharmaceuticals AB
P.O. Box 49013
100 28 Stockholm
Sweden
Manufacturer
Bluefish Pharmaceuticals AB
Gävlegatan 22
113 30 Stockholm
Sweden
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park,
Paola, PLA 3000
Malta
Local representative:
Bluefish Pharma S.L.U.,
AP 36007
2832094 Madrid, Sucursal 36
This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
Member State | Medicine name |
Germany | Venlafaxin Bluefish 75 Hartkapseln, retardiert |
Austria | Venlafaxin Bluefish 75 mg Hartkapseln, retardiert |
Denmark | Venlafaxin Bluefish XR 75 mg |
Spain | Venlafaxina Bluefish 75 mg Cápsulas de liberación prolongada EFG |
Finland | Venlafaxine Bluefish 75 mg depotcapseli, kova Venlafaxine Bluefish 75 mg depotkapsel, hård |
France | Venlafaxine Bluefish LP 75 mg gélules à libération prolongée |
Ireland | Venlablue XL 75 mg prolonged-release capsules, hard |
Iceland | Venlafaxine Bluefish 75 mg hart forðahylki. |
Italy | Venlafaxina ABC 75 mg Capsule a rilascio prolungato |
Norway | Venlafaxine Bluefish XR |
Poland | Venlafaxine Bluefish XL |
Portugal | Venlafaxina Bluefish XR |
United Kingdom (NI) | Venlablue XL 75 mg prolonged-release capsules, hard |
Sweden (RMS) | Venlafaxine Bluefish 75 mg depotkaplar, hårda |
Date of last revision of this leaflet: June 2023
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es